Click here to read the articles and view the interactive digital edition

Pharmaceutical Commerce - June 2025

Why driving results from such strategies—amid industry disruption—will be critical to success.

Building Agility and Adaptability Into Pharma Operations

The advantages and challenges associated with structuring a patient assistance program as a non-profit foundation.

Changing the PAP Model

An exploration into how flawed incentives and contractual loopholes between manufacturers and pharmacy benefit managers played their part.

Popping the Gross-to-Net Bubble, Part IV: Extreme Examples of Who Grew the Bubble

Articles

The June issue of Pharmaceutical Commerce highlights the importance of embracing agility—and adaptable strategies—to better navigate industry challenges.

The Art of Agility

Videos

In the second part of her Pharma Commerce video interview, LeAnn Boyd, Liviniti’s founder and CEO, discusses how this MFN executive order can affect players in the space that operate under a rebate-driven PBM model. 

Moving Beyond the Rebate-Driven Model

Pharma Pulse 6/18/25: The Complexities of Drug Discounting; How Clinical Operations Teams Are Adapting to Oncology Trial Challenges

A professor of food, pharma, and healthcare business at Saint Joseph’s University’s Erivan K. Haub School of Business.

Ways to address limitations while also enhancing the decision-making process.


Bolstering Health Technology Assessment With the Help of AI

Executive Director of the Otsuka Patient Assistance Foundation, Inc. (OPAF)

The advantages and challenges associated with structuring a patient assistance 
program as a non-profit foundation.

Changing the PAP Model 

Though this specific agreement centers around aerospace and automobiles, the greater supply chain will wait and see how Trump’s import taxes impact pharmaceuticals, a sector that faces a potential 25% tax on imports.

United States, United Kingdom Reach Tariff-Lowering Deal

Approaches powered by RWD can clear the way for a greater focus on patient-centered care.

Building Intelligent Pharma Supply Chain Management with Real-World Data

In the first part of her Pharma Commerce video interview, LeAnn Boyd, Liviniti’s founder and CEO, outlines the most critical root causes of rising healthcare and drug costs that the MFN executive order doesn’t address.

Analysis of the MFN Executive Order 

Pharma Pulse 6/17/25: How AI and Regulation are Reshaping the Future of Drug Safety; A Reflection on Our Path Forward

Senior Vice President, Market Development, at ConnectiveRx.

Doubling down on patient access and support fundamentals will win out over Washington’s next move.

Featured Content

Pharmaceutical Commerce - June 2025

Building Agility and Adaptability Into Pharma Operations

Changing the PAP Model

Popping the Gross-to-Net Bubble, Part IV: Extreme Examples of Who Grew the Bubble